Maria C Foss de Freitas (Maria C Foss-Freitas), MD, PhD
Research Investigator
Internal Medicine
[email protected]

Available to mentor
Maria C Foss de Freitas (Maria C Foss-Freitas), MD, PhD
Research Investigator
  • Qualifications
  • Center Memberships
  • Links
  • Recent Publications
    • Qualifications
    • Visiting Scholar
      University of Michigan Medical School, Ann Arbor, 2020
    • Fellowship in Endocrinology
      Sao Paulo University-Ribeirao Preto Medical School, Ribeirao Preto, 2001
    • Internal Medicine Residency
      Sao Paulo University-Ribeirao Preto Medical School, Brazil, 1999
    • Research Fellow
      Joslin Diabetes Center, Boston
    • Postdoctoral Fellow
      University of Michigan Medical School, Ann Arbor
    • PhD.
      Sao Paulo University (USP), Brazil, 2004
    • MD
      Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, 1996
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    Links
    • Bibliography from My NCBI
    Recent Publications See All Publications
    • Journal Article
      Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy.
      Foss-Freitas MC, Imam S, Neidert A, Gomes AD, Broome DT, Oral EA. Diabetes Care, 2024 Apr 1; 47 (4): 653 - 659. DOI:10.2337/dc23-1614
      PMID: 38300898
    • Journal Article
      Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
      Altarejos JY, Pangilinan J, Podgrabinska S, Akinci B, Foss-Freitas M, Neidert AH, Ray Y, Zheng W, Kim S, Kamat V, Huang M, Min S, Mastaitis J, Dominguez-Gutierrez G, Kim J-H, Stevis P, Huang T, Zambrowicz B, Olson WC, Godin S, Bradley E, Gewitz AD, Baker M, Hench R, Davenport MS, Chenevert TL, DiPaola F, Yancopoulos GD, Murphy AJ, Herman GA, Musser BJ, Dansky H, Harp J, Gromada J, Sleeman MW, Oral EA, Olenchock BA. Sci Transl Med, 2023 Nov 22; 15 (723): eadd4897 DOI:10.1126/scitranslmed.add4897
      PMID: 37992152
    • Journal Article
      Dietary Protein Restriction Improves Metabolic Dysfunction in Patients with Metabolic Syndrome in a Randomized, Controlled Trial.
      Ferraz-Bannitz R, Beraldo RA, Peluso AA, Dall M, Babaei P, Foglietti RC, Martins LM, Gomes PM, Marchini JS, Suen VMM, de Freitas LCC, Navegantes LC, Pretti MAM, Boroni M, Treebak JT, Mori MA, Foss MC, Foss-Freitas MC. Nutrients, 2022 Jun 28; 14 (13): DOI:10.3390/nu14132670
      PMID: 35807851
    • Journal Article
      Hyperinsulinemic-Euglycemic Clamp Strengthens the Insulin Resistance in Nonclassical Congenital Adrenal Hyperplasia.
      Delai A, Gomes PM, Foss-Freitas MC, Elias J, Antonini SR, Castro M, Moreira AC, Mermejo LM. J Clin Endocrinol Metab, 2022 Feb 17; 107 (3): e1106 - e1116. DOI:10.1210/clinem/dgab767
      PMID: 34693966
    • Journal Article
      Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study.
      Foss-Freitas MC, Akinci B, Neidert A, Bartlett VJ, Hurh E, Karwatowska-Prokopczuk E, Oral EA. Lipids Health Dis, 2021 Dec 5; 20 (1): 174 DOI:10.1186/s12944-021-01589-4
      PMID: 34865644
    • Journal Article
      Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis.
      Cook K, Ali O, Akinci B, Foss de Freitas MC, Montenegro RM, Fernandes VO, Gupta D, Lou K-J, Tuttle E, Oral EA, Brown RJ. J Clin Endocrinol Metab, 2021 Jul 13; 106 (8): e2953 - e2967. DOI:10.1210/clinem/dgab216
      PMID: 33822100
    • Journal Article
      The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity.
      Koo E, Foss-Freitas MC, Meral R, Ozer M, Eldin AJ, Akinci B, Miller N, Rothberg AE, Oral EA. Obesity (Silver Spring), 2021 Feb; 29 (2): 274 - 278. DOI:10.1002/oby.23049
      PMID: 33491315
    • Journal Article
      Diagnostic strategies and clinical management of lipodystrophy.
      Foss-Freitas MC, Akinci B, Luo Y, Stratton A, Oral EA. Expert Rev Endocrinol Metab, 2020 Mar; 15 (2): 95 - 114. DOI:10.1080/17446651.2020.1735360
      PMID: 32368944